Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Palisade Bio (PALI) EBT Margin (2016 - 2023)

Palisade Bio has reported EBT Margin over the past 11 years, most recently at 1011.6% for Q1 2023.

  • Quarterly EBT Margin changed N/A to 1011.6% in Q1 2023 from the year-ago period, while the trailing twelve-month figure was 5234.0% through Dec 2023, changed N/A year-over-year, with the annual reading at 5234.0% for FY2023, N/A changed from the prior year.
  • EBT Margin was 1011.6% for Q1 2023 at Palisade Bio, up from 137416.12% in the prior quarter.
  • Over five years, EBT Margin peaked at 1011.6% in Q1 2023 and troughed at 137416.12% in Q4 2020.
  • The 3-year median for EBT Margin is 73700.24% (2020), against an average of 67692.18%.
  • The largest YoY upside for EBT Margin was 6429700bps in 2020 against a maximum downside of -5243968bps in 2020.
  • A 3-year view of EBT Margin shows it stood at 84976.44% in 2019, then tumbled by -62bps to 137416.12% in 2020, then surged by 99bps to 1011.6% in 2023.
  • Per Business Quant, the three most recent readings for PALI's EBT Margin are 1011.6% (Q1 2023), 137416.12% (Q4 2020), and 73450.76% (Q3 2020).